1246248-51-0

Basic information

• Product Name: 1-(2-{[6-({4-[{3-[(tert-butoxycarbonyl)(methyl)amino]propyl}(methoxy)carbamoyl]phenyl}amino)hexanoyl](methyl)amino}ethyl)piperidin-4-yl biphenyl-2-ylcarbamate
• Synonyms: 1-(2-{[6-({4-[{3-[(tert-butoxycarbonyl)(methyl)amino]propyl}(methoxy)carbamoyl]phenyl}amino)hexanoyl](methyl)amino}ethyl)piperidin-4-yl biphenyl-2-ylcarbamate
• CAS NO: 1246248-51-0
• Molecular Weight: 787.012
• Mol File: 1246248-51-0.mol

Chemical Properties

• CAS DataBase Reference: 1-(2-{[6-({4-[{3-[(tert-butoxycarbonyl)(methyl)amino]propyl}(methoxy)carbamoyl]phenyl}amino)hexanoyl](methyl)amino}ethyl)piperidin-4-yl biphenyl-2-ylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-{[6-({4-[{3-[(tert-butoxycarbonyl)(methyl)amino]propyl}(methoxy)carbamoyl]phenyl}amino)hexanoyl](methyl)amino}ethyl)piperidin-4-yl biphenyl-2-ylcarbamate(1246248-51-0)
• EPA Substance Registry System: 1-(2-{[6-({4-[{3-[(tert-butoxycarbonyl)(methyl)amino]propyl}(methoxy)carbamoyl]phenyl}amino)hexanoyl](methyl)amino}ethyl)piperidin-4-yl biphenyl-2-ylcarbamate(1246248-51-0)

Safety Data

• Hazardous Substances Data: 1246248-51-0(Hazardous Substances Data)

Upstream product

• 25542-62-5 6-bromo-hexanoic acid ethyl ester 
• 98642-44-5 tert-butyl (3-hydroxypropyl)methylcarbamate 
• 273756-96-0 methanesulfonic acid 2-(tert-butoxycarbonyl-methyl-amino)propyl ester 
• 1246247-05-1 tert-Butyl 4-({6-[(2-{4-[(biphenyl-2-ylcarbamoyl)oxy]piperidin-1-yl}ethyl)(methyl)amino]-6-oxohexyl}amino)benzoate 
• 1246247-04-0 tert-Butyl 4-[(6-ethoxy-6-oxohexyl)amino]benzoate 
• 1246248-50-9 tert-Butyl [3-(methoxyamino)propyl]methylcarbamate 
• 1246247-06-2 4-({6-[(2-{4-[(biphenyl-2-ylcarbamoyl)oxy]piperidin-1-yl}ethyl)(methyl)amino]-6-oxohexyl}amino)benzoic acid 

Downstream Products

• 1246248-52-1 1-{2-[{6-[(4-{Methoxy[3-(methylamino)propyl]carbamoyl}phenyl)amino]hexanoyl}(meth yl)amino]ethyl}piperidin-4-yl biphenyl-2-ylcarbamate 

Relevant articles and documents

AMIDE DERIVATIVE

The present invention relates to a compound or a pharmacologically acceptable salt thereof that has an excellent antagonistic effect on a neurokinin NK1 receptor, a neurokinin NK2 receptor, and a muscarine M3 receptor and is useful as a therapeutic agent for bronchial asthma, chronic obstructive pulmonary disease, or the like. A compound represented by general formula (I): [wherein R1 represents a hydrogen atom, a C1-C6 alkyl group, or the like; R2 represents a hydrogen atom, a C1-C6 alkyl group, or the like; R3 represents a phenyl group that may be substituted with 1 to 5 group(s) independently selected from Substituent Group A, or the like; R4 represents a phenyl group that may be substituted with 1 to 5 group(s) independently selected from Substituent Group A, or the like; L1 represents a C1-C10 alkylene group or the like; L2 represents a carbonyl group, a group represneted by the formula -N(R5)-C(=O)-, a group represented by the formula -C(=O)-N(R5)-, or the like; R5 represents a hydrogen atom, a C1-C6 alkyl group, or the like; E represents a phenylene group that may be substituted with 1 to 4 group(s) independently selected from Substituent Group A, or the like; m is an integer of 1 to 4; n is an integer of 0 to 4; p is an integer of 0 to 2; q is an integer of 1 to 10; r is 1 or 2; s is 0 or 1; and Substituent Group A represents the group consisting of a halogen atom, a C1-C6 alkyl group, C1-C6 halogenated alkyl group, or the like] or a pharmacologically acceptable salt thereof.